Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine
(NEW YORK) -- Moderna announced Tuesday it has dosed its first participant in a phase III clinical trial of a combination influenza and COVID-19 vaccine.This phase will evaluate the safety and efficacy of the combo vaccine compared to flu and COVID vaccines that are... Read More.